Back to search

Aristotle University Of Thessaloniki (AUTH)

Τιτλοποίηση των δόσεων ηπαρίνης/πρωταμίνης με τη χρήση συσκευής οπτικής ανίχνευσης του χρόνου πήξης σε ασθενείς που υποβάλλονται σε καρδιοχειρουργικές επεμβάσεις με ελάχιστα επεμβατική εξωσωματική κυκλοφορία

Abstract

dc:description

Individualized heparin and protamine management is advocated as a strategy to reduce activation of the coagulation cascade and bleeding complications. However, its role in low anticoagulation protocols such as those implemented during Minimally Invasive Extracorporeal Circulation (MiECC) has not been investigated. Through this study on cardiac surgery patients, we aim to compare the conventional Activated Clotting Time (ACT) test with the effect of individualized heparin-protamine management (IHPT). This is a prospective, randomized, controlled trial. Patients undergoing elective cardiac surgery with MiECC were recruited. All patients were managed by the same anaesthetic, surgical and perfusion team. Patients were randomly allocated in the individualized heparin-protamine titration (IHPT) group and the conventional heparinization and reversal group (cACT). In the IHPT, the Hepcon HMS Plus (Medtronic, Minneapolis, MN) was used and in the cACT, the ACT Plus device (Medtronic, MN, USA). The primary outcome of the study was the total protamine dose administered. Secondary outcomes included the total heparin dose, transfusion requirements, postoperative bleeding, duration of mechanical ventilation and length of hospital stay. Patients in each group were divided in two subgroups according to the target ACT; those operated for coronary artery bypass grafting (CABG) using a target ACT >300s and the rest (non-CABG) patients operated with a target ACT >400s, respectively. Overall, a total of 132 patients were included and analyzed. The protamine dose was significantly reduced in the IHPT group; CABG (118 ± 24 mg vs. 163 ± 61; p<0.001) and non-CABG cases (151 ± 46 mg vs. 197 ±45 mg; p<0.001). Heparin requirements were significantly higher in the non-CABG subgroup of IHPT (34,539 ± 7,658 IU vs. 29,893 ± 9,037 IU; p=0.02). Concerning the computed total protamine:heparin ratio, for CABG it was equal to 0.45 (0.13) in the titration group versus 0.6 (0.25) in the cACT group (p=0.001) and for all other cases equal to 0.41 (0.13) versus 0.7 (0.15) respectively (p<0.001). Overall, no significant differences were found in terms of postoperative bleeding or transfusions. Regarding the non-CABG subgroup, the platelet count, the 1st and 2nd postoperative day was significantly elevated in the titration group. In conclusion, titration of heparin and protamine compared to a low heparin reversal ratio, results in reduced protamine dosing during cardiac surgery with MiECC.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Gkiouliava, Anna
  • Γκιουλιάβα, Άννα

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/54752

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Gkiouliava, Anna; Γκιουλιάβα, Άννα. Τιτλοποίηση των δόσεων ηπαρίνης/πρωταμίνης με τη χρήση συσκευής οπτικής ανίχνευσης του χρόνου πήξης σε ασθενείς που υποβάλλονται σε καρδιοχειρουργικές επεμβάσεις με ελάχιστα επεμβατική εξωσωματική κυκλοφορία. Aristotle University Of Thessaloniki (AUTH), 2023. http://hdl.handle.net/10442/hedi/54752